|NIH Human Embryonic Stem Cell Registry|
|Research Using This Line is Eligible for NIH Funding|
Detailed information for selected cell line:
|Cell Line:||HUES PGD 10|
|NIH Registration Number:||0179|
|NIH Approval Number:||NIHhESC-12-0179|
|Available for Distribution:||Yes|
HUES line recipients must provide documentation of ESCRO (or equivalent ethical) review for the research planned with the requested lines to Harvard University.
|NIH Restrictions:||(No Additional Restrictions)|
HUES PGD-10 was derived from an embryo tested using preimplantation genetic diagnosis (PGD) because one of the parents had been diagnosed with a balanced translocation [46, XY, t(2;16)(q21;q22)].
The embryo from which HUES PGD-10 was derived was diagnosed through PGD, using FISH, as having an extra copy of the long arm of chromosome 2, a missing arm of chromosome 16, as well as being monosomic for chromosomes 13 and 21. The line itself has not yet been karyotyped.
|Submitting Organization:||Harvard University|
|Provider Name:||Eggan Lab|
(Emails that are offensive or unrelated to stem cells will be deleted.)